PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 144 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,701,368 | -45.3% | 941,274 | -9.4% | 0.01% | -44.4% |
| Q2 2023 | $28,700,427 | -1.1% | 1,039,105 | -17.7% | 0.01% | -10.0% |
| Q1 2023 | $29,031,181 | +246910.8% | 1,262,259 | +17.2% | 0.01% | +233.3% |
| Q4 2022 | $11,753 | -99.8% | 1,077,226 | +31.3% | 0.00% | 0.0% |
| Q3 2022 | $6,916,000 | +2.5% | 820,438 | -3.8% | 0.00% | +50.0% |
| Q2 2022 | $6,745,000 | -67.0% | 852,775 | -1.2% | 0.00% | -66.7% |
| Q1 2022 | $20,434,000 | -31.7% | 862,892 | -1.3% | 0.01% | -33.3% |
| Q4 2021 | $29,913,000 | +92.8% | 874,651 | -0.1% | 0.01% | +80.0% |
| Q3 2021 | $15,518,000 | -56.3% | 875,732 | +10.7% | 0.01% | -54.5% |
| Q2 2021 | $35,499,000 | +109.1% | 791,016 | +20.6% | 0.01% | +83.3% |
| Q1 2021 | $16,979,000 | +29.7% | 656,101 | +1.0% | 0.01% | +20.0% |
| Q4 2020 | $13,095,000 | -2.3% | 649,540 | -5.2% | 0.01% | -16.7% |
| Q3 2020 | $13,397,000 | +10.4% | 685,256 | -0.2% | 0.01% | +20.0% |
| Q2 2020 | $12,130,000 | +155.0% | 686,897 | +2.0% | 0.01% | +150.0% |
| Q1 2020 | $4,756,000 | +0.6% | 673,648 | +0.4% | 0.00% | 0.0% |
| Q4 2019 | $4,729,000 | -46.2% | 670,751 | -8.3% | 0.00% | -33.3% |
| Q3 2019 | $8,784,000 | -2.5% | 731,305 | -1.7% | 0.00% | 0.0% |
| Q2 2019 | $9,010,000 | +8.0% | 744,058 | +12.1% | 0.00% | 0.0% |
| Q1 2019 | $8,343,000 | +152.9% | 663,777 | +35.4% | 0.00% | +200.0% |
| Q4 2018 | $3,299,000 | -12.9% | 490,267 | +33.2% | 0.00% | 0.0% |
| Q3 2018 | $3,787,000 | +147.4% | 368,017 | +61.5% | 0.00% | 0.0% |
| Q2 2018 | $1,531,000 | – | 227,817 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
| Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
| Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
| RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
| Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
| COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
| Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
| BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
| HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |